Pharming Group (OTCMKTS:PHGUF) Sets New 52-Week High - Time to Buy?
Pharming Group (OTCMKTS:PHGUF) Hits New 12-Month High - Here's What Happened...
MarketBeat·1d ago
More News
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's Why...
MarketBeat·3d ago
Pharming Group (NASDAQ:PHAR) Stock Price Up 11% - Time to Buy?
Pharming Group (NASDAQ:PHAR) Stock Price Up 11% - What's Next...
MarketBeat·6d ago
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's What Happened...
MarketBeat·9d ago
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Here's Why
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell...
MarketBeat·12d ago
Pharming Group (NASDAQ:PHAR) Sets New 12-Month High - Still a Buy?
Pharming Group (NASDAQ:PHAR) Reaches New 52-Week High - Here's What Happened...
MarketBeat·14d ago
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade
The mean of analysts' price targets for Pharming Group (PHAR) points to an 81.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·15d ago
Pharming Group (OTCMKTS:PHGUF) Hits New 52-Week High - Here's What Happened
Pharming Group (OTCMKTS:PHGUF) Sets New 1-Year High - What's Next...
MarketBeat·19d ago
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Still a Buy...
MarketBeat·21d ago
Arcutis Biotherapeutics, Inc. (ARQT) Soars to 52-Week High, Time to Cash Out?
Arcutis Biotherapeutics (ARQT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.